Journal profile

Current opinion in lipidology

Publisher: Lippincott Williams & Wilkins
ISSN0957-9672 | 1473-6535 FormatPrint StatusCurrently indexed
Official Website Verify CrossRef

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.64
Citation rate 4.52 410 total citations
h5-index 27 h5 depth signal
Cited share 77.1% 74 of 96
Total citations 410 Citation footprint
Metric signal 5.52 External metric anchor
Self-citation 4.4% 18 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 202
Canada 80
Netherlands 74
United Kingdom 63
Australia 50

Citing Fields of Research

Lipids 439
Cardiology 202
Endocrinology & Metabolism 133
Diabetes 127
Genetics & Genomics 90

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 3,408 Articles tracked across the journal lifetime
Indexed publication set 96 74 cited publications
Last 12 months 42 3.8 publications/month
Open access share 19.0% 8 OA publications in the last year
Leading citing country United States 202 citing publications
Leading citing field Lipids 439 citing publications
Latest tracked publication 19 September 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v5n1, 1994-
PubMed
v5n1, 1994-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Lipids Cardiology Endocrinology & Metabolism Genetics & Genomics

Broad Categories

Biochemistry Lipids

MeSH Descriptors

Lipids

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
DOI 10.1097/mol.0000000000001062

CRISPR therapy for dyslipidemia

Open DOI
Stephen J. Nicholls
Purpose of review: Several lipid and lipoprotein risk factors play an important role in the causality of atherosclerotic cardiovascular disease. Many therapies are limited by suboptimal long-term adherence. This narrative review summariz...
03
Open DOI
Danh Q. Nguyen, Neha J. Pagidipati, Ann Marie Navar
Purpose of review: Oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors represent a new generation of lipid-lowering therapies that combine the potency of injectable PCSK9 inhibitors with the convenience of oral administ...
07
Open DOI
Annelise Genoux, Thibaut Jamme, Laurent O. Martinez
Purpose of review: Sitosterolemia is a rare autosomal recessive lipid disorder caused by biallelic pathogenic variants in ABCG5 or ABCG8 , resulting in excessive intestinal absorption and impaired biliary excretion of plant sterols. Alth...
08
Open DOI
Emily Halbedl, Edward A. Fisher
Purpose of review: Despite aggressive cholesterol lowering, many patients continue to experience cardiovascular events (“residual risk”), emphasizing the need for novel risk reduction strategies. This review highlights recent advances in...
09
DOI 10.1097/mol.0000000000001051

Lipids in endothelial-to-mesenchymal transition

Open DOI
Christina K. Tripsas, Abigail Y. Tsai, Jeffrey J. Hsu
Purpose of review: Endothelial-to-mesenchymal transition (EndMT) has been implicated in the development of cardiovascular disease, including atherosclerosis. EndMT is a complex continuum with multiple involved pathways, each with differe...
10
Open DOI
Olcay Aksoy, Yin Tintut, Linda L. Demer
Purpose of review: Lipids and lipoproteins have established roles in calcific atherosclerosis, but there is less awareness of their role in calcific aortic valve disease (CAVD). Clinical studies link CAVD with severe hypercholesterolemia...

Bibliographical & Catalog Notes

Each issue also has a distinctive title.

Includes a section called: Bibliography of the current world literature.

Place of publication varies.

Also issued online.

Vol. 5, no. 3 (1994)19940426 Notice published Printed on acid-free paper